Vita34 ApS: Financial statements 2020
CVR: 27511759
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Vita34 ApS (CVR 27511759) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 5,176,046 and a net result of DKK 2,644,645 compared with DKK -231,088 the year before. That is an increase of 112.6% compared with the year before. Equity in the 2020 report amounted to DKK -6,004,919.
- Gross Profit
- DKK 5,176,046
- Profit/Loss
- DKK 2,644,645
- Equity
- DKK -6,004,919
- Total Assets
- DKK 20,403,483
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 5.2M | 2.6M | -6M | 0 |
| 2019 | - | 2.4M | -231K | -8.6M | 0 |
| 2018 | - | 4.8M | -4M | -8.4M | 12 |
| 2017 | - | 3.3M | -6.1M | -4.4M | 16 |
| 2016 | - | 3.1M | -5.9M | 1.7M | 17 |
Official annual report
How creditworthy is Vita34 ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Vita34 ApS has published its annual report for 2019. Gross profit came to DKK 2,434,727, and the net result was DKK -231,088.
About Vita34 ApS
Vita34 ApS is a Danish company of the type Anpartsselskab based in Søborg, founded in 2004. The company is registered under the industry Drift af sundhedsvæsen i øvrigt i.a.n.. The company was previously named StemCare ApS and BIOBANK DANMARK ApS. The management consists of Marion Bartel and Vivien Weise. The company is owned by FamiCord AG. The company has 2 employees (2018). In 2025, the company reported a gross profit of DKK 3,842,095 and a net result of DKK 1,034,065 compared with DKK 1,030,138 the year before. Equity in the 2025 report amounted to DKK 5,982,880.